Sign In
Buy ADAP
$0.0549
+0 (+0%)
At Close: Feb 20, 2026
Stocks To Watch: Walmart, Target, Kandi And Gold vs. Bitcoin
08:30am, Saturday, 15'th Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
All You Need to Know About Adaptimmune Therapeutics PLC (ADAP) Rating Upgrade to Buy
04:00pm, Tuesday, 11'th Aug 2020
Adaptimmune Therapeutics PLC (ADAP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Announcing: Adaptimmune Therapeutics (NASDAQ:ADAP) Stock Soared An Exciting 367% In The Last Year
11:40am, Monday, 10'th Aug 2020
It might be of some concern to shareholders to see the Adaptimmune Therapeutics plc (NASDAQ:ADAP) share price down 14...
Did The Underlying Business Drive Adaptimmune Therapeutics' (NASDAQ:ADAP) Lovely 367% Share Price Gain?
11:25am, Monday, 10'th Aug 2020
Adaptimmune Therapeutics plc (NASDAQ:ADAP) shareholders have seen the share price descend 14% over the month. But that...
Canadian outdoor collective project misfires, offering lessons to other small cannabis growers
11:00am, Friday, 07'th Aug 2020
Canadian cannabis grower Mark Spear had a plan: Form an outdoor cannabis collective with some like-minded farmers, raise capital through equity crowdfunding and start growing high-quality outdoor flow
Mizuho Securities Sticks to Their Hold Rating for Adaptimmune Therapeutics (ADAP) - Markets
05:00pm, Thursday, 06'th Aug 2020
Mizuho Securities analyst Mara Goldstein maintained a Hold rating on Adaptimmune Therapeutics (ADAP – Research Report) today and set a
Adaptimmune Reports Q2 Financial Results and Business Update
11:30am, Thursday, 06'th Aug 2020
\- Reported responses in multiple solid tumor types during ASCO with updates at upcoming congresses in Q4 -\- Continued progress toward launch of ADP-A2M4 for sarcoma in the US in 2022 with ongoing en
U.S. Stock Futures Edge Higher, Gold Rallies
09:04am, Wednesday, 05'th Aug 2020
Bull market in gold continued, sending prices over $2,000 a troy ounce for second day, while U.S. Treasury yields remained near this year’s lows.
Treasury yields move higher as markets monitor stimulus talks
07:52am, Wednesday, 05'th Aug 2020
U.S. government debt prices were lower Wednesday morning as lawmakers remain deadlocked over further stimulus.
Europe Points Higher Ahead Of Busy Data Day, Gold Shines
12:00am, Wednesday, 05'th Aug 2020
Market Overview Analysis by City Index (Fiona Cincotta) covering: GBP/USD, XAU/USD, Gold Futures, SPDR® Gold Shares. Read City Index (Fiona Cincotta)'s latest article on Investing.com
Pale Blue Portfolio Review, May 18-July 31: 17 Buys, 2 Sells, 15.45% Gains
10:41pm, Tuesday, 04'th Aug 2020
The Pale Blue Portfolio gained 15.45% between May 18 and July 31. I slightly adjusted my purchasing strategy in July.
Stock futures flat as investors await stimulus bill, more earnings
10:05pm, Tuesday, 04'th Aug 2020
The Dow Jones Industrial Average rose for its third straight day on Tuesday.
Small-Business Hiring Casts a Dark Cloud Over Coming Jobs Report
05:17pm, Tuesday, 04'th Aug 2020
The decline in small-business hiring last month came as Covid-19 cases began to surge anew, especially in the South and West, prompting some states to pause or roll back reopenings.
Adaptimmune Therapeutics (NASDAQ:ADAP) versus Voyager Therapeutics (NASDAQ:VYGR) Financial Comparison
03:00am, Tuesday, 04'th Aug 2020
Adaptimmune Therapeutics (NASDAQ:ADAP) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the str
Automatic Data Processing (NASDAQ:ADP) Rating Lowered to Strong Sell at Zacks Investment Research
02:58am, Tuesday, 04'th Aug 2020
Zacks Investment Research cut shares of Automatic Data Processing (NASDAQ:ADP) from a hold rating to a strong sell rating in a research note issued to investors on Friday, Zacks.com reports. The broke
